Documentos relacionados

1. [Demographics, morbidity, and mortality febrile neutropenic adult patients treated with cefepime].
2. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
3. Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality.
4. Outcomes of Febrile Neutropenia in Children With Cancer Managed on an Outpatient Basis: A Report From Tertiary Care Hospital From a Resource-limited Setting.
5. Echinocandins versus non-echinocandins for empirical antifungal therapy in patients with hematological disease with febrile neutropenia: A systematic review and meta-analysis.
6. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.
7. Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
8. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
9. Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
10. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.